Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Grant: Prevalence and treatment of low HDL cholesterol among primary care patients with type.... (0.08 sec) 

Prevalence and treatment of low HDL cholesterol among primary care patients with …

- diabetesjournals.org
RW Grant, JB Meigs - Diabetes Care, 2007 - Am Diabetes Assoc
RESULTS—Nearly half (49.5%) of patients had low HDL cholesterol (<40 mg/dl for men, <50
mg/dl for women). Low HDL cholesterol was independently associated with prevalent cardiovascular
disease (CVD), younger age, and higher A1C levels. Nearly two-thirds of patients (63.0%) ...
Cited by 15 - Related articles - BL Direct - All 5 versions

[CITATION] Heterogeneity of LDL particle number in patients with type 2 diabetes and LDLc< …


WC Cromwell, JD Otvos - Am J Cardiol, 2006
Cited by 3 - Related articles

[CITATION] Remnant lipoproteins are related to intima-media thickness of the carotid, …


F Karpe, S Boquist, R Tang… - J Lipid Res, 2001
Cited by 3 - Related articles

[CITATION] Inflammation in diabetes mellitus: role of PPARalpha and PPARgamma agonists


P Libby, J Plutzky - Am J Cardiol, 2007
Cited by 4 - Related articles

[CITATION] Defective antioxidative capacity of small dense HDL3 particles in type 2 diabetes: …


E Nobecourt, S Jacquminet, B Hansel… - Diabetologia, 2006
Cited by 2 - Related articles

[CITATION] Serum lipids and breast cancer risk: a cohort study of Danish women


AP Hoyer, G Engholm - Cancer Causes Control, 1992
Cited by 2 - Related articles

Biological surrogates for enhancing cardiovascular risk prediction in type 2 …


LD St. Clair, CM Ballantyne - The American Journal of Cardiology, 2007 - Elsevier
The identification of individuals at increased risk for cardiovascular disease (CVD) events is the
critical first step toward reducing CVD morbidity and mortality. Accurate models for cardiac risk
stratification benefit high-risk patients, who stand to gain the most from aggressive ...
Cited by 10 - Related articles - All 33 versions

Expert commentary: the safety of fibrates in lipid-lowering therapy


WV Brown - The American Journal of Cardiology, 2007 - Elsevier
The use of fibrates in the management of lipoprotein disorders has a history dating back to the
mid-1960s. This group of drugs has now been tested in several large long-term trials with cardiovascular
end points. Overall, there is good evidence for the reduction of cardiovascular disease in ...
Cited by 11 - Related articles - All 14 versions

[CITATION] American Association of Clinical Endocrinologists/American Thyroid Association/ …


H Gharib, RM Tuttle, HJ Baskin, LH Fish, PA Singer, MT … - Endocr Pract, 2004
Cited by 3 - Related articles

Introducing the thyroid gland as another victim of the insulin resistance syndrome


J Rezzonico, M Rezzonico, E Pusiol, F Pitoia, H … - Thyroid, 2008 - liebertonline.com
Background: Insulin is a thyroid growth factor that stimulates proliferation of thyroid cells in
culture. In order to evaluate the effects of insulin resistance (IR) on the thyroid gland, we developed
a prospective study in eu- thyroid women. Methods: One hundred eleven women (mean ...
Cited by 4 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google